Providing Market Intelligence for 40 Years

In The News

The Apple Watch Is Scaling Back Its Health Features

The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.

"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.

'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'" 

From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.

Previously In The News

Smart Home Evolution: Elephant in the Room

While I’m eager to watch the unfolding evolution of smart home technologies, with mind-blowing features like voice-enabled technology, machine learning, virtual reality, location services, and demand...

The Sound Of The Internet Of Things (And Why It Matters For Brands)

In the next five years, Business Insider estimates that brands are going to spend around $5 trillion on the Internet of Things. For a third year in a row, the subject has dominated CES, the global con...

The two, opposing IoT r/evolutions in play

Before we go any further, let’s look at the vastness of the IoT space for a moment. The global Internet of Things market will grow to $1.7 trillion in 2020 from $655.8 billion in 2014. According to Ga...

Netflix, Inc. (NFLX): William Blair's Bull Case Points To $185 Price Target

William Blair upgraded Netflix, Inc. (NASDAQ:NFLX) to Outperform in August 2016 and believes there continues to be upside potential for the streaming video leader. Through William Blair's research, it...